milnubes.

Milnubes / Reviews / Product profile

Canalogy Green Tea Extra: does the ingredient list mention CBD?

The shop puts CBD in the product name. Scroll down to the composition and the ingredient it actually names and measures is green tea extract. That gap matters more than the word “Extra” on the listing.

Milnubes editorial desk ·

Close-up of a circular ridged cream-coloured lid on a green surface.
Editorial illustration of the product format, generated with Magnific for the CBD Green Tea Extra profile.
Published product details
Listed pack90 tablets weighing 22.5 g in total
Quantified ingredient50 mg of Camellia sinensis extract per tablet
Declared extract ratio4:1, equivalent to 200 mg of starting tea
CBD in the published formulaNo amount or ingredient identified as cannabidiol

Reading past the product name

Both the English and Spanish pages list Camellia sinensis extract, calcium carbonate, cellulose and other tablet ingredients. Neither list identifies cannabidiol. That omission cannot establish that the tablets contain zero CBD. Confirming the contents would take a batch label or an analysis. Someone comparing measured amounts of CBD simply has no figure here to work with.

What 4:1 actually measures

The shop equates 50 mg of extract with 200 mg of starting green tea. This ratio tells you how the two quantities relate. It leaves open how much caffeine or how much epigallocatechin gallate (EGCG) the tablet contains. The 50 mg also refers to the whole extract, so it cannot double as a figure for CBD. The front of the Canalogy container shows 200 mg and 90 tablets. Cannabidiol is not named on that visible panel either.

Why EFSA distinguishes tea from concentrated extracts

In assessing catechins and possible liver effects, EFSA treats traditional infusions and concentrated supplements separately. EU rules for products covered by the green tea extract regulation require specific information about EGCG. The online composition gives no EGCG figure. It does not support an exposure estimate or a prediction that the tablets will stimulate or relax the person taking them.

Two reviewers and an unanswered question

On 20 January 2026, a reviewer writing in Portuguese and marked by the shop as a verified buyer said they had only just started and would judge later. The English-language review comments on appearance. Neither reports an effect observed over time.

Sources

Further reading